ANDA 91202, held by Mylan Pharma. Lopinavir; Ritonavir.
As of Nov 16, 2026, ANDA 91202 (Lopinavir; Ritonavir), held by Mylan Pharma, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 8, 2011 | Original application | Tentative approval | None posted |
| Lopinavir; Ritonavir100MG; 25MG · tablet; oral | Lopinavir; Ritonavir | None (tentative approval) |
| Lopinavir; Ritonavir200MG; 50MG · tablet; oral | Lopinavir; Ritonavir | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters